Ultrasound-guided Anterior Hydrodilatation in Shoulder Adhesive Capsulitis
Launched by TANTA UNIVERSITY · Jan 14, 2022
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
patients was randomized into two equal groups. Group I received ultrasound-guided hydrodilatation with corticosteroid, saline, and local anesthetic via posterior intra-articular approach; group II received the same ultrasound-guided hydrodilatation via anterior rotator interval approach.
Both groups received guided stretching exercises for 3 months after injection. Baseline and 3 months evaluation of pain by visual analogue scale (VAS), shoulder pain and disability index (SPADI), and range of motion (ROM) had been recorded for all patients.
A statistical power analysis was performed after...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients aged 35 to 60 years,
- • patients who suffered pain and stiffness in only one shoulder, for 1 to 6 months
- • patients who had restriction of passive motion.
- Exclusion Criteria:
- • patients with previous trauma,
- • patients with neurological
- • patients with endocrinal diseases
- • patients with shoulder tumor
- • patients with arthritis
- • people who had received intra-articular shoulder injection within the last 6 months.
- • Patients with tendon tear
About Tanta University
Tanta University is a prestigious academic institution located in Egypt, dedicated to advancing medical research and education. As a clinical trial sponsor, Tanta University leverages its extensive resources and expertise to conduct innovative research initiatives aimed at improving health outcomes. The university collaborates with a network of healthcare professionals, researchers, and institutions to facilitate rigorous clinical trials across various medical disciplines. Committed to ethical standards and scientific integrity, Tanta University strives to contribute to the global body of knowledge while fostering the next generation of medical professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, Gharbia, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials